Startup News     |     Silicon Valley Blog     |     Startup Podcasts     
   


Corthera Closes a $23 Million Financing Round

In this series C funding, new investor Caxton Advantage Life Sciences Fund, a fund focused on development-stage public and private companies in the life sciences field, joined existing top-tier investors Domain Associates and Kleiner, Perkins, Caufield & Byers in the financing round. (read full story at: pharmalive.com)
Tags: corthera   caxton   kleiner perkins   pharma  |  Category: Funding Announcement  |  Email this  |  Share This

Submitted by:

Comments


Who voted for this story